Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/30/2008US20080269335 Crth2 Receptor Antagonists
10/30/2008US20080269334 Highly Concentrated Pourable Aqueous Solutions Of Potassium Ibuprofen, Their Preparation And Their Use
10/30/2008US20080269333 Anthranilic acid derivatives useful in treating infection with hepatitis c virus
10/30/2008US20080269332 Eyelash enhancement composition and method of treatment
10/30/2008US20080269331 Omega -3 series polyunsaturated fatty acids are selected from eicosapentanoic acid, docosahexaenoic acid, eicosapentanoic acid, ethyl ester, docosahexaenoic acid, ethyl ester; infarct of the myocardium; coronary ischemia; atrial fibrillation
10/30/2008US20080269330 Nutrition Containing Fat Blend
10/30/2008US20080269329 Process for Production of Microbial Fat/Oil Containing Discretional Amount of Diacylglycerol and Said Fat/Oil
10/30/2008US20080269328 cardiovascular benefits of diets supplemented with "designer oils" containing low ratios of n-6:n-3 fatty acids from different sources, either fish oil (source of docosahexanoic acid (DHA) and eicosapentaenoic acid (EPA) or flaxseed oil (source of alpha-linolenic acid (ALA);
10/30/2008US20080269327 Magnesium threonate, useful for administration to a subject presenting magnesium deficiency, mild cognitive impairment, Alzheimer's disease, attention deficit hyperactivity disorder, ALS, Parkinson's disease, diabetes, migraine, anxiety disorder,hypertension
10/30/2008US20080269326 1-dimethylamino-3-(3-methoxyphenyl)-2methyl-pentan-3-ol; 3-(3-dimethylamino-1-hydroxy-1,2-dimethylpropyl)-phenol; treating diabetic peripheral neuropathy
10/30/2008US20080269325 Methods to Relieve Pain
10/30/2008US20080269324 long chain retinyl ketone, ester, amide, retinimide etc. free of N-(4-hydroxyphenyl)retinamide); inhibits, antagonizes, or short-circuits the visual cycle at a step of the visual cycle that occurs outside a disc of a rod photoreceptor
10/30/2008US20080269323 Use of 4-(nitrooxy)-butyl-(s)-2-(6-methoxy-2-naphthyl)-propanoate for treating pain and inflammation
10/30/2008US20080269322 Substituted Aminophenylsulfonamide Compounds as Hiv Protease Inhibitor
10/30/2008US20080269321 Therapeutic Combinations for the Treatment or Prevention of Depression
10/30/2008US20080269320 Cocoa Extracts
10/30/2008US20080269319 Biologically active taxane analogs and methods of treatment
10/30/2008US20080269318 Treatment of age-related macular degeneration using inhibitors of complement factor d
10/30/2008US20080269317 Compounds for Covalent Binding to MD-2 and Effect on the Immune Response
10/30/2008US20080269316 Pharmaceutical Compositions Comprising Levetiracetam and Process for Their Preparation
10/30/2008US20080269315 Crystalline form
10/30/2008US20080269314 Process for Forming Amorphous Atorvastatin
10/30/2008US20080269313 Prolyl Oligopeptidase Inhibitors Ameliorating Recovery From Brain Trauma
10/30/2008US20080269312 1-(4-tert-Butyl-benzenesulfonyl)-2,3-dihydro-1H-indole-2-carboxylic acid methyl ester; 5-Bromo-1-(4-tert-butyl-benzenesulfonyl)-2,3-dihydro-1H-indole-2-carboxylic acid; therapeutic treatment in immune-mediated diseases, e.g. intestinal disorders, such as autoimmune and inflammatory diseases
10/30/2008US20080269311 vildagliptin, MK-0431, saxagliptin etc as dipeptidyl-peptidase inhibitor; tegaserod, cisapride, nor-cisapride, renzapride, zacopride, mosapride, prucalopride, buspirone, and norcisapride interect with a 5-HT4 receptor, and cilansetron, ramosetron, azasetron, dolasetron, ramosetron interect with 5-HT3 R
10/30/2008US20080269310 Synergistic Combinations
10/30/2008US20080269309 Phosphoinositide-dependent kinase-1 (PDK-1) inhibitors; for the treatment and prevention of cancer in humans; 4-[5-(2-Phenanthracenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenecarboxamide
10/30/2008US20080269308 Allantoin-containing skin cream
10/30/2008US20080269307 Quantity of acetyl L-carnitine to be administered is 0.1 to 2 g/day, while the dose of biotin is 1 to 8 mg/day
10/30/2008US20080269306 Antidepressant Medicament Comprising Idazoxan and a Selective Serotonin Reuptake Inhibitor
10/30/2008US20080269305 R)-N-{2-Butyl-3-[2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl]-3H-imidazol-4-ylmethyl}-2-(2-hydroxycarbamoyl-3-phenyl-propionylamino)succinamic Acid; AT1 receptor antagonist and neprilysin (NEP) enzyme inhibition activity; hypertension, heart failure
10/30/2008US20080269304 Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use
10/30/2008US20080269303 Diaryloxazole carboxamide derivatives for treating a disease selected from appetite disorder, metabolic disorder, gastrointestinal disorder, inflammatory phenomena, immune system disease, psychotic disorder, alcohol dependency and nicotine dependency
10/30/2008US20080269302 Macrocyclic Tertiary Amine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
10/30/2008US20080269301 Coloring an additive with a colorant such as food yellow No. 5, mixing the resultant additive with a base compound such as amlodipine or a pharmaceutically acceptable salt thereof, and tableting the mixture; improved in light stability
10/30/2008US20080269300 Substituted Phenylaminothiazoles and Use Thereof
10/30/2008US20080269298 anticarcinogenic agent, 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(trifluoromethyl)-benzyl]oxy}thiophene-2-carboxamide; for treatment of susceptible neoplasm selected from breast, colon, lung, prostate cancer, lymphoma, leukemia, endometrial cancer, melanoma, ovarian, pancreatic, head and neck
10/30/2008US20080269297 Dissolving base addition salt of esomeprazole in water containing at least one amine, adding at least one acid, allowing esomeprazole non-salt form to crystallize and isolating the formed crystals; for treatment of gastrointestinal disorders
10/30/2008US20080269296 Diaryl ethers as opioid receptor antagonists
10/30/2008US20080269295 Substituted thiazoles and their use for producing drugs
10/30/2008US20080269294 Benzamide Compounds Useful as Histone Deacetylase Inhibitors
10/30/2008US20080269293 1-[2-(5-Methyl-2-o-tolyl-2H-pyrazol-3-yloxy)-phenyl]-3-(4-trifluoromethoxy-phenyl)-urea, for example; useful as P2Y1 antagonists for treating thromboembolic disorders
10/30/2008US20080269292 N-deacetylthiocolchicine deriatives, their use and pharmaceutical formulations containing them
10/30/2008US20080269291 Chemical Compounds
10/30/2008US20080269290 Indoles
10/30/2008US20080269289 Vanilloid receptor ligand compounds, pharmaceutical compositions containing them, a method of producing them and the use thereof to treat pain and various other conditions
10/30/2008US20080269288 2-[(3R)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanyl-pyridin-2-yl]-3-piperidyl]acetic acid, for example; compounds possess human 11- beta-hydroxysteroid dehydrogenase type1 enzyme (11 beta HSD1) inhibitory activity and accordingly have value in treatment of disease states including metabolic syndrome
10/30/2008US20080269287 Substituted Pyridone Derivative
10/30/2008US20080269286 Disubstituted Phenylpiperidines as Modulators of Cortical Catecholaminergic Neurotransmission
10/30/2008US20080269285 Use of these iminoxylitol compounds for treatment of Gaucher's disease
10/30/2008US20080269284 e.g. 4-[(3,5-bistrifluoromethylbenzyl)-(2-propyl-2H-tetrazol-5-yl)amino]-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid isopropyl ester; cholesterol ester transfer protein (CETP) inhibitors; increasing plasma HDL- cholesterol, decreasing plasma LDL- cholesterol; atherosclerosis
10/30/2008US20080269283 Arylsulfones and uses related thereto
10/30/2008US20080269282 Including semicarbazide-sensitive amine oxidase (vascular adhesion protein-1, VAP-I), and therapeutic use in inflammatory diseases, diabetes and its associated complications, atherosclerosis, neurodegenerative diseases, obesity, hypertension and cancer; N1-hydroxy-N2-[(4-bromophenyl)carbonyl]glycinamide
10/30/2008US20080269281 Novel Beta-Agonists, Method for Producing Them and Their Use as Drugs
10/30/2008US20080269280 Antiinflammatory agents; rheumatic diseases; multiple sclerosis
10/30/2008US20080269279 Substituted furo[2,3-B] pyridine derivatives as cannabinoid-1 receptor modulators
10/30/2008US20080269278 Treatment of Impaired Respiratory Function with Gaboxadol
10/30/2008US20080269277 Pyrrolopyridine-2-Carboxylic Acid Hydrazides
10/30/2008US20080269276 Compositions useful for treating irritable bowel syndrome
10/30/2008US20080269275 Moderation of melanocyte stimulating hormone; psychological disorders; analgesics; anxiolytic agents; bipolar disorders;obesity; eating disorders; antidepressants
10/30/2008US20080269274 Using imiquimod; rubbing into surface
10/30/2008US20080269273 Administering loratadine and montelukast; cardiovascular disorders; antiallergens; antiinflammatory agents
10/30/2008US20080269272 Anticancer agents; psoriasis; prevent activation of hedgehog gene passageways
10/30/2008US20080269271 Analgesics; antidepressants; neurodegenerative diseases; antiepileptic agents; cognition activators; antitussive agents; incotinence; irritable bowel syndrome; stroke; vision defects; antiinflammatory agents; skin disorders; diarrhea; eating disorders
10/30/2008US20080269270 Triol form of rosuvastatin and synthesis of rosuvastatin
10/30/2008US20080269269 Protein kinase inhibitor; purity; polymorphism
10/30/2008US20080269268 Substituted Phenylamino-Pyrimidines
10/30/2008US20080269267 Anticancer agents; rheumatic diseases; asthma; chronic obstructive pulmonary disease; neurodegenerative diseases; metabolic disorders
10/30/2008US20080269266 Moderation of insulin-like growth factor receptors; anticancer agents
10/30/2008US20080269265 Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
10/30/2008US20080269264 Kinase inhibitor; amtiinflammatory agents; rheumatic diseases; osteoarthritis; asthma
10/30/2008US20080269262 Therameutin Modulators
10/30/2008US20080269261 Combination of Zd6474 and Pemetrexed
10/30/2008US20080269260 Using a purine compound; antiallergens; antiinflammatory agents; cognition activators; drug abuse; schizophenia; Alzheimer's disease; Parkinson's disease
10/30/2008US20080269259 Regulation of Autophagy and Cell Survival
10/30/2008US20080269257 Use of Substituted 2-Pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A] Pyrimidin-4-one and 7-Pyrimidinyl-2,3-dihydroimidazo[1,2-A] Pyrimidin-5(1H)one Derivatives
10/30/2008US20080269256 Central nervous system disorders; antidepressants;anxiolytic agents; psychological disorders; antiepileptic agents; schizophrenia; Alzheimer's disease; antiischemic agents; antiepileptic agents
10/30/2008US20080269255 Hypotensive agents; atherosclerosis; congestive heart failure; hypertrophy; cardiomyopathy; diabetic nephropathy; restenosis; cognition activator; Alzheimer's disease; anxiolytic agents
10/30/2008US20080269254 Antiproliferative agents; anticancer agents; graft versus host disease; rheumatic diseases; vision defects; cardiovascular disorders
10/30/2008US20080269253 Pain therapy; headaches; neurodegenerative diseases; stroke; skin disorders; antiischemic agents; Huntington's disease; antiulcer agents; inflammatory bowel disorders;amyotropic lateral sclerosis
10/30/2008US20080269252 Use of Compounds Derived From Pyrimidinetrione as Acetyl Cholinesterase Inhibitors, Compositions Containing Said Derivatives, and the Uses Thereof
10/30/2008US20080269251 Central nervous system disorders; psychological disorders; anxiolytic agents; antidepressants; Parkinson's disease; Alzheimer's disease; analgesics; neurodegenerative diseases; sexual disorders
10/30/2008US20080269250 Pyrrolidine and Piperidine Acetylene Derivatives for Use as Mglur5 Antagonists
10/30/2008US20080269249 Controlling intraocular pressure
10/30/2008US20080269248 Tartrate and Malate Salts of Trans-1-((1R,3S)-6-Chloro-3-Phenylindan-1-Yl)-3,3-Dimethylpiperazine
10/30/2008US20080269247 Chemokine Inhibiting Piperazine Derivatives and Their Use to Treat Myocarditis
10/30/2008US20080269246 Cognition activators; psychological disorders; autism; mental retardation; obessive compulsive disorders ; administering ziprasidone
10/30/2008US20080269245 Histone deacetylase inhibitors; anticancer agents; antiprotozoa agents
10/30/2008US20080269244 Suppression cytokines , tumor necrosis factor
10/30/2008US20080269243 Thiadiazole compounds and methods of use
10/30/2008US20080269242 Central nervous system disorders in mammals; antidepressants; bipolar disorders; schizophrenia; autism; attention deficit disorders; post-traumatic stress disorders
10/30/2008US20080269241 Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
10/30/2008US20080269240 Immunomoderator; antiallergens; viricides; anticancer agents; asthma; rhinitis; hepatitis; skin disorders
10/30/2008US20080269239 Antiinflammatory agents; asthma;antiarthritic agents; psoriasis; inflammatory bowel disorders; rhinitis; dermatitis; antiallergens
10/30/2008US20080269238 Thiazolopyrimidine Derivative
10/30/2008US20080269237 Histone deacetylase inhibitor; anticancer agents; antiproliferative agents; antitumor agents; psoriasis; piperazine compound containing a carbamic acid group
10/30/2008US20080269236 Novel 1,2,4 Oxadiazole Compounds and Methods of Use Thereof
10/30/2008US20080269235 e.g. 5-Acetyl-4-[(3,5-difluorophenyl)amino]-2-ethyl-6-phenylpyridazin-3(2H)-one; Tumor Necrosis Factor alpha antagonist; antiinflammatory agent, autoimmune diseases; chronic obstructive pulmonary disease, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease
10/30/2008US20080269234 Such as 7-((cyclohexyl)methyl) pyrido(2,3-d )pyridazine-4(5H)-one; anticancer agents; antiinflammatory agents;antiischemic agents; antidiabetic agents
10/30/2008US20080269233 Piperidinoyl-Pyrrolidine and Piperidinoyl-Piperidine Compounds
1 ... 3018 3019 3020 3021 3022 3023 3024 3025 3026 3027 3028 3029 3030 3031 3032 3033 3034 3035 3036 3037 3038 ... 7860